{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:47Z","timestamp":1707524147768},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,19]]},"DOI":"10.7759\/cureus.11046","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T01:51:13Z","timestamp":1603158673000},"source":"Crossref","is-referenced-by-count":0,"title":["Suspecting Cardiac Amyloidosis in Congestive Heart Failure"],"prefix":"10.7759","author":[{"given":"Emad U","family":"Alatassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iyiad","family":"Alabdul Razzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini G","year":"2003","unstructured":"Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003, 349:583-596. 10.1056\/NEJMra023144","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-002-0016-1","article-title":"Primary systemic amyloidosis","volume":"3","author":"Gertz MA","year":"2002","unstructured":"Gertz MA, Rajkumar SV. Primary systemic amyloidosis. Curr Treat Options in Oncol. 2002, 3:261-271. 10.1007\/s11864-002-0016-1","journal-title":"Curr Treat Options in Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey SW","year":"1998","unstructured":"Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM. 1998, 91:141-157. 10.1093\/qjmed\/91.2.141","journal-title":"QJM"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan M","year":"2016","unstructured":"Grogan M, Scott CG, Kyle RA, et al.. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol. 2016, 68:1014-1020. 10.1016\/j.jacc.2016.06.033","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore JD","year":"2018","unstructured":"Gillmore JD, Damy T, Fontana M, et al.. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. 2018, 39:2799-2806. 10.1093\/eurheartj\/ehx589","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-301924","article-title":"Cardiac transthyretin amyloidosis","volume":"98","author":"Dungu JN","year":"2012","unstructured":"Dungu JN, Anderson LJ, Whelan CJ, Hawkins PN. Cardiac transthyretin amyloidosis. Heart J. 2012, 98:1546-1554. 10.1136\/heartjnl-2012-301924","journal-title":"Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidosis","volume":"112","author":"Falk","year":"2005","unstructured":"Falk, RH.. Diagnosis and management of the cardiac amyloidosis. Circulation. 2005, 112:2047-2060. 10.1161\/CIRCULATIONAHA.104.489187","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.08.043","article-title":"Noninvasive diagnosis of biopsy-proven cardiac amyloidosis","volume":"43","author":"Rahman JE","year":"2004","unstructured":"Rahman JE, Helou EF, Gelzer-Bell R, et al.. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol. 2004, 43:410-415. 10.1016\/j.jacc.2003.08.043","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz MA","year":"2015","unstructured":"Gertz MA, Benson MD, Dyck PJ, et al.. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015, 66:2451-2466. 10.1016\/j.jacc.2015.09.075","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.09.105","article-title":"Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis","volume":"103","author":"Ruberg FL","year":"2009","unstructured":"Ruberg FL, Appelbaum E, Davidoff R, et al.. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol. 2009, 103:544-549. 10.1016\/j.amjcard.2008.09.105","journal-title":"Am J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.593","article-title":"Efficacy of chemotherapy for light-chain amyloidosis in patients presenting with symptomatic heart failure","volume":"67","author":"Sperry BW","year":"2016","unstructured":"Sperry BW, Ikram A, Hachamovitch R, Valent J, Vranian MN, Phelan D, Hanna M. Efficacy of chemotherapy for light-chain amyloidosis in patients presenting with symptomatic heart failure. J Am Coll Cardiol. 2016, 67:2941-2947. 10.1016\/j.jacc.2016.03.593","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000890","article-title":"Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes","volume":"8","author":"Maurer MS","year":"2015","unstructured":"Maurer MS, Grogan DR, Judge DP, et al.. Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes. Circ Heart Fail. 2015, 8:519-526. 10.1161\/CIRCHEARTFAILURE.113.000890","journal-title":"Circ Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-017-9601-z","article-title":"Heart transplantation in cardiac amyloidosis","volume":"22","author":"Sousa M","year":"2017","unstructured":"Sousa M, Monohan G, Rajagopalan N, Grigorian A, Guglin M. Heart transplantation in cardiac amyloidosis. Heart Fail Rev. 2017 , 22:317-327. 10.1007\/s10741-017-9601-z","journal-title":"Heart Fail Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00805.x","article-title":"Heart transplantation in a 68-year-old patient with senile systemic amyloidosis","volume":"5","author":"Fuchs U","year":"2005","unstructured":"Fuchs U, Zittermann A, Suhr O, Holmgren G, Tenderich G, Minami K, Koerfer R. Heart transplantation in a 68-year-old patient with senile systemic amyloidosis. Am J Transplant. 2005, 5:1159-1162. 10.1111\/j.1600-6143.2005.00805.x","journal-title":"Am J Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.12.013","article-title":"Outcomes in patients with cardiac amyloidosis undergoing heart transplantation","volume":"8","author":"Barrett CD","year":"2020","unstructured":"Barrett CD, Alexander KM, Zhao H, et al.. Outcomes in patients with cardiac amyloidosis undergoing heart transplantation. JAAC Heart Fail.. 2020, 8:461-468. 10.1016\/j.jchf.2019.12.013","journal-title":"JAAC Heart Fail."},{"key":"ref16","article-title":"Pretransplantation risk factors for death after heart transplantation: a multi-institutional study. The Transplant Cardiologists Research Database Group","volume":"12","author":"Bourge RC","year":"1993","unstructured":"Bourge RC, Naftel DC, Costanzo-Nordin MR, et al.. Pretransplantation risk factors for death after heart transplantation: a multi-institutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant. 1993, 12:549-562.","journal-title":"J Heart Lung Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult heart transplantation report","volume":"91","author":"Khush KK","year":"2019","unstructured":"Khush KK, Cherikh WS, Chambers DC, et al.. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult heart transplantation report. 2019, 91:1056-1066. 10.1016\/j.healun.2019.08.004"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2011.08.086","article-title":"Heart transplantation in patients aged 70 years and older: a two-decade experience","volume":"43","author":"Daneshvar D","year":"2011","unstructured":"Daneshvar D, Czer LS, Phan A, et al.. Heart transplantation in patients aged 70 years and older: a two-decade experience. Transplant Proc. 2011, 43:3851-3856. 10.1016\/j.transproceed.2011.08.086","journal-title":"Transplant Proc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/38929-suspecting-cardiac-amyloidosis-in-congestive-heart-failure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:02Z","timestamp":1707506882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/38929-suspecting-cardiac-amyloidosis-in-congestive-heart-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.11046","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,19]]}}}